Presentation
5 March 2021 Monitoring peripheral edema in heart failure patients and a normal cohort using molecular chemical imaging (MCI)
Aaron Smith, Shona D. Stewart, Marlena Darr, Arash Samiei, Robert Schweitzer, Matthew Nelson, Patrick Treado, Jeffrey Cohen, James C. Post
Author Affiliations +
Abstract
Heart failure (HF) has a significant impact on patient outcomes and health care costs. Objective monitoring of pitting edema level of a HF patient may help clinicians reduce the volume of patient re-admissions. To address this, ChemImage is developing a Molecular Chemical Imaging (MCI) device for noninvasive measurement of peripheral edema level in HF patients. In an initial clinical study, edema grade was predicted in HF patients with 86% accuracy. Results from a follow-up clinical trial demonstrating the capability of MCI to monitor changes in a HF patient’s peripheral edema over time during the course of treatment will be presented.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Aaron Smith, Shona D. Stewart, Marlena Darr, Arash Samiei, Robert Schweitzer, Matthew Nelson, Patrick Treado, Jeffrey Cohen, and James C. Post "Monitoring peripheral edema in heart failure patients and a normal cohort using molecular chemical imaging (MCI)", Proc. SPIE 11638, Biophotonics in Exercise Science, Sports Medicine, Health Monitoring Technologies, and Wearables II, 1163809 (5 March 2021); https://doi.org/10.1117/12.2577989
Advertisement
Advertisement
KEYWORDS
Heart

Imaging spectroscopy

Blood

Clinical trials

Human subjects

Imaging devices

Back to Top